Balaji Amines Ltd

Balaji Amines Ltd

₹ 2,233 -0.62%
19 Jun 10:02 a.m.
About

Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India. [1]

Key Points

Product Portfolio[1]
The company has a diversified product portfolio with a basket of ~30 different products. These products are categorized under 3 main categories i.e. Amines, Amine derivatives, and Specialty & Other chemicals. Its products include Methyl Amines, Ethyl amines, Amino Ethanol, acetamide, amine hydrochloride, methyl urea, choline chloride, morpholine, etc.
Its products find application in many industries like Pharma, Agro, Rubber chemicals, photographic chemicals, rocket fuel, pesticides, solvents, performance chemicals, water treatment chemicals, etc.

  • Market Cap 7,235 Cr.
  • Current Price 2,233
  • High / Low 2,736 / 1,960
  • Stock P/E 35.3
  • Book Value 531
  • Dividend Yield 0.45 %
  • ROCE 16.8 %
  • ROE 12.5 %
  • Face Value 2.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 11.8% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
414 451 526 565 780 670 628 586 471 464 381 383 414
285 309 394 410 584 455 455 458 378 366 327 309 316
Operating Profit 129 142 131 155 196 215 173 128 93 98 54 74 98
OPM % 31% 31% 25% 27% 25% 32% 27% 22% 20% 21% 14% 19% 24%
4 3 3 4 5 5 3 3 6 6 7 8 9
Interest 4 3 4 4 7 3 2 3 3 2 2 2 1
Depreciation 8 10 11 10 11 11 11 12 11 11 11 11 12
Profit before tax 120 131 119 145 183 205 162 115 85 90 48 70 93
Tax % 26% 26% 26% 30% 29% 28% 27% 27% 35% 25% 24% 21% 22%
89 97 88 102 131 148 119 84 55 68 36 56 72
EPS in Rs 26.08 27.89 24.61 27.64 33.55 37.95 28.57 19.31 14.63 16.27 10.71 15.24 21.00
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
509 608 616 640 668 858 940 935 1,308 2,314 2,346 1,642
429 517 515 514 519 676 747 754 935 1,691 1,736 1,318
Operating Profit 80 91 102 127 149 182 193 181 373 623 609 324
OPM % 16% 15% 17% 20% 22% 21% 21% 19% 29% 27% 26% 20%
4 3 4 3 9 12 4 5 6 15 15 30
Interest 25 32 35 22 13 9 13 23 18 17 12 6
Depreciation 13 16 20 19 20 19 20 32 34 42 46 45
Profit before tax 46 46 51 88 126 166 165 131 327 578 567 302
Tax % 32% 27% 35% 34% 34% 32% 29% 26% 25% 28% 28% 23%
31 34 33 58 82 113 117 97 243 418 406 232
EPS in Rs 9.62 10.34 10.25 17.78 25.42 34.93 36.27 32.34 73.51 113.71 100.47 63.22
Dividend Payout % 14% 10% 12% 11% 9% 7% 8% 10% 5% 5% 10% 17%
Compounded Sales Growth
10 Years: 10%
5 Years: 12%
3 Years: 8%
TTM: -30%
Compounded Profit Growth
10 Years: 20%
5 Years: 12%
3 Years: -5%
TTM: -37%
Stock Price CAGR
10 Years: 43%
5 Years: 43%
3 Years: -4%
1 Year: -8%
Return on Equity
10 Years: 23%
5 Years: 22%
3 Years: 22%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 165 195 221 274 356 461 568 652 888 1,243 1,548 1,715
209 262 256 173 105 152 227 260 127 101 58 20
139 158 139 152 168 229 244 195 289 395 351 405
Total Liabilities 519 620 623 605 635 848 1,046 1,113 1,310 1,745 1,963 2,146
234 325 341 341 325 316 320 573 543 681 780 898
CWIP 63 8 3 16 25 123 269 46 173 141 113 203
Investments 20 20 0 0 0 0 0 48 0 0 73 0
202 267 278 248 284 409 457 446 594 923 996 1,046
Total Assets 519 620 623 605 635 848 1,046 1,113 1,310 1,745 1,963 2,146

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
94 111 56 85 60 140 94 144 110 220 382 220
-86 -50 -4 -29 -10 -135 -119 -130 -62 -147 -186 -160
-10 -53 -55 -54 -55 16 21 -26 -37 -57 -81 -75
Net Cash Flow -2 7 -3 2 -5 21 -4 -12 11 16 115 -15

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 74 79 71 71 68 73 65 81 85 93 59 71
Inventory Days 66 87 114 80 106 70 116 77 64 66 89 116
Days Payable 42 83 48 58 55 56 60 42 44 54 18 31
Cash Conversion Cycle 99 83 136 93 119 87 120 116 104 105 129 156
Working Capital Days 75 67 95 70 78 74 89 102 91 94 94 115
ROCE % 19% 18% 18% 23% 30% 32% 24% 18% 35% 49% 36%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
53.68% 53.70% 53.70% 53.70% 53.70% 53.70% 53.70% 53.71% 53.71% 53.71% 53.71% 53.71%
2.35% 4.00% 3.90% 3.99% 4.51% 4.55% 4.39% 4.45% 4.55% 4.52% 4.58% 4.92%
0.30% 0.48% 0.16% 0.16% 0.18% 0.24% 0.37% 0.34% 0.18% 0.90% 1.43% 1.48%
43.67% 41.82% 42.24% 42.15% 41.61% 41.51% 41.53% 41.50% 41.57% 40.88% 40.31% 39.91%
No. of Shareholders 55,74273,3411,07,4121,21,0441,19,6511,20,7851,29,7021,36,6441,40,9571,44,9901,41,4171,38,017

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls